{{item}}
The clinical use of the potent antitumor activity of TNF-α has been limited by the proinflammatory side effects including fever, dose-limiting hypotension, hepatotoxicity, intravascular thrombosis, and hemorrhage. Designing clinically applicable TNF-α mutants with low systemic toxicity has been an intense pharmacological interest. Human TNF-α, which binds to the murine TNF-α55 but not to the murine TNF-α75, exhibits retained antitumor activity and reduced systemic toxicity in mice compared with murine TNF-α, which binds to both murine TNF receptors. Based on these results, many TNF-α mutants that selectively bind to TNF-α55 have been designed. These mutants displayed cytotoxic activities on tumor cell lines in vitro, and exhibited lower systemic toxicity in vivo.
货号 | 103-01v |
产地 | 美国 |
缩写 | rhTNF-α variant |
规格 | 10ug |
用途 | 科研 |
储存 | -20度 |
运输 | 干冰 |
No Publication available at this time
There are no product questions yet.
人
人
货号 | 产品名称 | 规格 | 价格 | 指令 | |
107-12 | 重组人β动物纤维 rhBTC | 5ug | $95 | + | |
108-02 | 重组人骨形成蛋白-2 rhBMP-2 | 2ug | $95 | + | |
108-04 | 重组人骨形成蛋白-4 rhBMP-4 | 2ug | $95 | + | |
108-07 | 重组人骨形成蛋白-7 rhBMP-7 | 2ug | $95 | + | |
108-08 | 重组人骨保护素 rHuOPG-Fc | 10ug | $95 | + | |
108-09 | 重组人NOGGIN蛋白 rhNOGGIN | 5ug | $95 | + | |
301-01 | 重组人生长激素 rhGF | 20ug | $95 | + |